News

Institutional

27 de July de 2017

São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending  patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
 
Click on Download to access the full text of the decision.
Back

Last related news

3 de July de 2025

Kasznar Leonardos is shortlisted as Firm of the Year at the LMG Life Sciences Americas Awards

We are proud to announce that Kasznar Leonardos has been shortlisted as a finalist in the “Firm of the Year” category at Kasznar Leonardos is shortlisted as Firm of the Year at the LMG Life Sciences Americas Awards

  • Kasznar Leonardos
  • Ler notícia

    26 de June de 2025

    Kasznar Leonardos was ranked in Chambers & Partners Brazil: Industries & Sectors 2025

    We are proud to announce that Kasznar Leonardos has been ranked in the Chambers Brazil Guide: Industries & Sectors 2025. We were Kasznar Leonardos was ranked in Chambers & Partners Brazil: Industries & Sectors 2025

  • Kasznar Leonardos
  • Ler notícia

    12 de June de 2025

    Kasznar Leonardos is ranked on Leaders League 2025

    We are pleased to announce that, once again, we have been ranked by Leaders League Brazil, a respected publication in the legal field. Kasznar Leonardos is ranked on Leaders League 2025

  • Kasznar Leonardos
  • Ler notícia
    plugins premium WordPress